Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Director at $HON Sells 2,367 Shares

Automated

D SCOTT DAVIS, a director at $HON, sold 2,367 shares of the company on 02-19-2026 for an estimated $568,080. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.1% of their shares of this class of stock. Following this trade, they now own 31,081 shares of this class of $HON stock.

$HON Insider Trading Activity

HON Insider Trades

$HON insiders have traded $HON stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $HON stock by insiders over the last 6 months:

  • ROBERT D. MAILLOUX (Vice President & Controller) sold 5,274 shares for an estimated $1,260,486
  • D SCOTT DAVIS sold 2,367 shares for an estimated $568,080

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$HON Hedge Fund Activity

We have seen 1,112 institutional investors add shares of $HON stock to their portfolio, and 1,423 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$HON Revenue

HON Quarterly Revenue

$HON had revenues of $6.9B in Q4 2025. This is a decrease of -32.0% from the same period in the prior year.

You can track HON financials on Quiver Quantitative's HON stock page.

$HON Congressional Stock Trading

Members of Congress have traded $HON stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $HON stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$HON Analyst Ratings

Wall Street analysts have issued reports on $HON in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 01/30/2026
  • JP Morgan issued a "Overweight" rating on 01/30/2026
  • Citigroup issued a "Buy" rating on 01/12/2026
  • B of A Securities issued a "Underperform" rating on 11/18/2025
  • TD Cowen issued a "Buy" rating on 11/10/2025
  • RBC Capital issued a "Outperform" rating on 10/27/2025

To track analyst ratings and price targets for $HON, check out Quiver Quantitative's $HON forecast page.

$HON Price Targets

Multiple analysts have issued price targets for $HON recently. We have seen 10 analysts offer price targets for $HON in the last 6 months, with a median target of $247.5.

Here are some recent targets:

  • Deane Dray from RBC Capital set a target price of $268.0 on 01/30/2026
  • Stephen Tusa from JP Morgan set a target price of $260.0 on 01/30/2026
  • Joseph O'Dea from Wells Fargo set a target price of $235.0 on 01/30/2026
  • Julian Mitchell from Barclays set a target price of $259.0 on 01/30/2026
  • Andrew Kaplowitz from Citigroup set a target price of $265.0 on 01/30/2026
  • Brett Linzey from Mizuho set a target price of $240.0 on 01/05/2026
  • Alexander Virgo from Evercore ISI Group set a target price of $255.0 on 12/15/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles